Medical Developments in the Fight Against COVID-19
Development
of a vaccine for the novel disease coronavirus has become a public health
priority, and pharmaceutical companies and researchers across the country are
hard at work. After the development of the vaccine and preclinical testing,
there are three phases of human testing before it is submitted to the FDA for
approval. According to the doctors at the National Institute of Allergy and
Infectious Disease, the earliest a coronavirus vaccine would be deployable
would be a year to a year and a half from now. Even as countries entertain the
thought of relaxing lockdown and restarting life within the COVID era, the
novel coronavirus continues to say more lives. As of now, COVID-19 has infected
about 4.5 million people across the planet and caused 3,03,651 fatalities.
Until there’s a vaccine for this novel disease it is up to us to protect
ourselves. Following CDC guidelines and using medical essentials like
sanitizers, masks, disposable
bed sheet, and disposable bags can help us stay safe.
Currently,
the top candidates for COVID-19 vaccination are:-
- mRNA-1273- This has received
approval from the FDA (US Food and Drug Administration) to conduct the
phase 2 clinical trials of its potential COVID-19 vaccine candidate. It is
important to notice that Moderna has already conducted phase 1 trials of
its vaccine candidate mRNA-1273 in Seattle, Washington.
- Novavax Inc- One of the top
candidates of the potential COVID-19 vaccine, Novavax Inc recently
received funding of 388 million dollars from the Coalition for Epidemic
Preparedness Innovation. Dr. Gregory Glenn, president of research and
development for Novavax, said that the vaccine candidate NVX-CoV2373 has
shown promising results.
- INOVIO Pharmaceuticals is also
in a process of creating a DNA-based vaccine candidate in its San Diego
lab. The Plymouth Meeting-based biopharmaceutical company completed phase
1 of a clinical study on 40 healthy volunteers. Phase 2 is set to take
place in the last week of May where the 40 volunteers are going to be
injected with its vaccine candidate INO-4800.
- BNT162- US drug maker Pfizer has
teamed up with a German company BNTECH to develop a vaccine for COVID-19.
Both the businesses are working together on four RNA vaccine candidates.
Their vaccine candidate ‘BNT162’ is predicated on messenger RNA (mRNA)
technology and therefore the company has already begun clinical trials in
Germany. They are getting to start dosing patients for the US-based
clinical trials in early July.
- ChAdOx1 nCoV-19- A potential
coronavirus vaccine is being developed by the University of Oxford and it
has partnered up with UK-based AstraZeneca for the same. It is interesting
to note that the vaccine ‘ChAdOx1 nCoV-19’ was generated within three
months by the University’s Jenner Institute. To make the vaccine work, the
scientists used a weakened strain of cold virus (adenovirus) that causes
infections in chimpanzees. While a clinical test on humans already began
in late April, the doctors conducted a crucial trial on monkeys.
- London based cigarette company
British American Tobacco has also developed a vaccine using protein from
tobacco leaves and is ready for a human trial. The company said that its
experimental vaccine has shown a positive immune response in the
pre-clinical trial and now they are waiting for approval from the U.S.
Food and Drug Administration (FDA) after which it might proceed to phase 1
trial on humans.
- Bacille Calmette-Guérin- India
will begin clinical trials of its Bacille Calmette-Guérin (BCG) vaccine on
6000 high-risk individuals. It will be done to understand its safety and
efficacy in boosting immunity in the fight against COVID-19 disease and
whether or not the BCG shots can reduce the severity of this highly
infectious disease. The Bacillus Calmette-Guerin (BCG) vaccine is used
against tuberculosis to boost the immunity of the individual. Bharat
Biotech International Ltd (BBIL) has teamed up with the Indian Council for
Medical Research (ICMR) to develop a COVID-19 vaccine. One of the world’s
largest vaccine makers of the world by volume, Pune’s Serum Institute of
India is working with the University of Oxford to make millions of
potential coronavirus vaccine doses. The Indian government has also
allocated Rs 100 crore from the PM-CARES fund to support the initiative of
producing a COVID vaccine.
Our
life post coronavirus won’t return to normal soon and we have to equip
ourselves with essential gear to make sure that we’re ready to fight against
this virus. Online medical stores like www.smartmedicalbuyer.com are providing every crucial
product or technology that should be present at our homes and at the hospitals
from surgical hand sanitizers to disposable plastic bedsheets, from safety
goggles to infrared thermometer everything is available. Researchers,
scientists, and doctors are doing their best and so should we.
Comments
Post a Comment